A 45-day longitudinal study tracked daily anxiety relief in 416 medical cannabis patients. Cannabis-use days showed larger same-day reductions, but the design limits causal conclusions. Here’s what the data support, and what they don’t.
DOH sets conditions on proposed medical cannabis legalization | Philippine News Agency
WHY IT MATTERS: If the Philippines establishes a regulated medical cannabis program, patients in the country who currently have no legal access to cannabinoid therapies for conditions like chronic pain, epilepsy, or cancer-related symptoms could gain physician-supervised treatment options through a formal compassionate access pathway. CLINICAL OVERVIEW: The Philippine Department of Health is establishing conditions for a proposed medical cannabis legalization framework that would include compassionate access pathways for patients alongside expanded research initiatives and formal regulatory oversight. This approach mirrors the structured medical cannabis programs that have been successfully implemented in dozens of countries worldwide, where physician-supervised access is paired with robust safety monitoring.
The House Committee on Dangerous Drugs, together with the Committee on Health … – Facebook
WHY IT MATTERS: When countries like the Philippines move toward legalizing medical cannabis, it expands the global research landscape and may eventually improve the quality and diversity of clinical evidence that informs treatment protocols everywhere, including for patients currently under care. CLINICAL OVERVIEW: The Philippine House of Representatives is advancing legislative efforts through its committees on dangerous drugs and health to establish a medical cannabis framework for qualified patients, including a regulatory system and provisions for further research into therapeutic applications. This type of legislative movement in Southeast Asia reflects a broader global trend of countries reevaluating restrictive cannabis policies in light of mounting clinical evidence supporting cannabinoid therapies for conditions like chronic pain, epilepsy, and chemotherapy-induced nausea.
CBD and Liver Enzymes: What the New JAMA Study Actually Shows
A new peer-reviewed study sent ripples through the CBD world—but what does it actually say about liver health? Spoiler: it’s not as simple as “CBD is dangerous.” When you zoom in on the details, the real story is about dose, data, and the difference between panic and perspective.
When Confidence Replaces Competence: A Rebuttal to WSJ’s Cannabis Coverage
Cherry-picked studies and confident tone aren’t substitutes for scientific rigor. In today’s media landscape, it’s easy to mistake conviction for credibility—but real science demands nuance, context, and humility. This piece calls out the dangerous illusion of “Google expertise” and challenges us to raise the bar for what counts as informed commentary.
Your Heart on Weed: 7 Surprising Facts About Cannabis Cardiovascular Risk
This sweeping review of cannabis and cardiovascular risk might sound scary—but once you peek under the hood, the engine starts to sputter. Missing context, vague definitions, and unresolved confounders mean the real danger here might be poor science—not pot. Read on to learn why this paper says more about the need for better research than it does about your risk of heart attack.
7 Smart Reasons People Use Cannabis for Anxiety Relief
Anxiety doesn’t always knock politely—it barges in, rewires your nervous system, and dares you to function. While traditional medicine often hands out the same tired prescription, cannabis is quietly helping millions find calm in the chaos—without the emotional flatline. If you’ve ever wondered whether relief could come with fewer side effects and more humanity, this post is for you.
5 Reasons CBD CBG Topicals For Eczema Care is Amazing
A recent pilot study suggests that a CBD CBG topical for eczema might offer more than a passing fad. With significant improvements in hydration, barrier repair, and inflammation, cannabinoids are making a case for inclusion in dermatologic care. While it’s far from a clinical revolution, the data are compelling enough to earn a deeper look—and maybe a patch test.
5 Exciting Insights from the MedCan 3 Trial
MedCan 3: A Landmark Study on Medicinal Cannabis for Cancer Symptom Management Read The Study Publication The MedCan 3 study is a highly anticipated clinical trial investigating the potential of...
Cannabis in Pregnancy: 5 Crucial Insights
Cannabis in Pregnancy: 5 Crucial Insights Essential Science and Real-World Guidance for Expectant Mothers In today’s fast-paced world—where stress, politics, and the endless digital hustle often leave us questioning every decision—the...